Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis (Journal article)

Siamopoulos, K. C./ Elisaf, M. S./ Bairaktari, H./ Pappas, M. B./ Sferopoulos, G. D./ Nikolakakis, N. G.

Full metadata record
DC FieldValueLanguage
dc.contributor.authorSiamopoulos, K. C.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorBairaktari, H.en
dc.contributor.authorPappas, M. B.en
dc.contributor.authorSferopoulos, G. D.en
dc.contributor.authorNikolakakis, N. G.en
dc.rightsDefault Licence-
dc.subjectApolipoproteins A/blooden
dc.subjectApolipoproteins B/blooden
dc.subjectBody Mass Indexen
dc.subjectCase-Control Studiesen
dc.subjectCholesterol, HDL/blooden
dc.subjectCholesterol, LDL/blooden
dc.subjectCross-Sectional Studiesen
dc.subjectMiddle Ageden
dc.subject*Peritoneal Dialysis, Continuous Ambulatoryen
dc.subject*Renal Dialysisen
dc.subjectRisk Factorsen
dc.subjectSerum Albumin/analysisen
dc.titleLipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysisen
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.abstractOBJECTIVE: Dyslipidemia possibly contributes to the vascular complications commonly afflicting uremic patients. Lipoprotein (a) [Lp(a)] has been identified as an independent risk factor for atherosclerotic vascular disease. The aim of our study was to compare lipidparameters, including Lp(a), between hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients. DESIGN: A cross-sectional study. SETTING: University Medical Center. PARTICIPANTS: Forty CAPD and 40 HD patients carefully matched for age, sex, body mass index (BMI), smoking habits, and duration of dialysis were studied. A group of 40 healthy individuals matched for age, sex, BMI, and smoking habits was used as control. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Serum lipid parameters and atherogenic risk ratios were the main outcome measures. RESULTS: Both groups of dialysis patients had increased serum triglycerides and decreased levels of ApoA1 and HDL cholesterol compared to controls. Moreover, the risk ratios total cholesterol/HDL cholesterol and LDL cholesterol/HDL cholesterol were significantly higher, and the ratio ApoA1/ApoB was significantly lower in both groups of patients in comparison to the normal subjects. Both groups of dialysis patients exhibited decreased ratios of LDL cholesterol/ApoB and HDL cholesterol/ApoA1, suggesting the presence of compositional lipoprotein changes. CAPD patients had a more atherogenic lipid profile compared to HD patients, since they exhibited higher levels of total and LDL cholesterol, of ApoB as well as of the ratios total cholesterol/HDL cholesterol and LDL cholesterol/HDL cholesterol, and lower levels of the ratio ApoA1/ApoB compared to HD patients. Both groups of dialysis patients had increased serum Lp(a) levels. Even though CAPD patients had higher serum Lp(a) levels than HD patients, the differences between these two groups were only marginally statistically significant (p = 0.056 by Mann-Whitney U-test). Uremic dyslipidemia was positively correlated with serum albumin levels in both groups of patients. CONCLUSION: CAPD patients exhibit a more atherogenic lipid profile than that of HD patients. The marked disturbances in Lp(a) levels may further increase the vascular risk in both groups of patients.en
heal.journalNamePerit Dial Inten
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.